The issue with the comparison is that its not an Apple to Apple...

The issue with the comparison is that its not an Apple to Apple comparison

Vericel doesn't have an Australian cdi listed on the asx with a large number of short sellers

If rcel didn't have AVH to deal with, it would have probably had a similar share price trajectory to many other American businesses during 2020 as their markets went through the roof (asx has struggled & still hasn't returned to pre covid crash levels)

Unfortunately AVH started rcel at such a high price that it wasn't able to sustain

Every time it tries to have a rally, too many shareholders are taking profits to keep the share price at the highs

Any new shareholders from mid 2020 should be doing fine
Some better than others, even without trading

Another issue with your comparison is epicell was approved in 2016 (I believe)
Recell more than 2 years later in late 2018
You're comparing 2 different businesses at different cycles
Imagine comparing AVH to CSL for example
Very unfair comparison

The problem with avita is its trying to rush sales & expansion at such a heavy cost (Australians don't like that, Americans not so fussed)
So share price has been supressed
But if successful, they would have achieved what their goal was in a shorter time frame

But Australians are day traders
They jump onboard when everyone is buying (no matter the share price)
Then once the rally is over they take their profits
Only those with high averages will struggle unless they trade to bring their averages down

You can see quite clearly with the very large fluctuations in share prices

It's just unfortunate during late 2019 where the share price was too high that those that bought during that period have suffered.

You're entitled to do as you like with your investment money

But I just cant agree with the comparison